← Who reports today · Health Care
COR · Q3 FY2026
Archived report (Q3 FY2026). Latest deep dive →
The quarter in brief
Revenue grew 5.1% y/y to $84.75B, operating margin 1.3% vs 1.1%, net income $764M (+11.1% y/y).
Net income attributable to the company
$764M
up 11.1% y/y
Total revenues
$84,755M
up 5.1% y/y
Operating income
$1,120M
up 29.1% y/y
All figures in $M.
| Line item | Amount and change |
|---|---|
| Total revenues | $84,755 · +5.1% |
| Costs and expenses (calculated) | $83,635 · +4.8% |
| Operating income | $1,120 · +29.1% · 1.3% margin |
| Other income (expense), net (calculated) | $124 · vs $28.6 |
| Income before income taxes | $996 · +11.2% |
| Income tax expense | $220 · +6.4% · 22.0% effective rate |
| Net income attributable to noncontrolling interests | $13.1 · +470% |
| Net income attributable to the company | $764 · +11.1% · 0.9% margin |
Verdict: revenue grew 5.1% y/y to $84.75B, operating margin 1.3% vs 1.1%, net income $764M (+11.1% y/y).
Source and notation
Source: SEC XBRL of Cencora's 10-Q (SEC EDGAR); revenue and net income are confirmed by the 8-K press release of 08/05/2026. The release carries no income statement, so the chart is built from XBRL totals: costs and other items are calculated as differences between reported totals.
Open as an image: COR, Q3 FY2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0
Cite / embed this chart
Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).
Chart: “COR Q3 FY2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/cor/q3-fy2026. Licensed under CC BY 4.0.
<figure> <a href="https://whoreportstoday.com/t/cor/q3-fy2026"><img src="https://whoreportstoday.com/t/cor/q3-fy2026/sankey.png" alt="COR Q3 FY2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a> <figcaption>Source: <a href="https://whoreportstoday.com/t/cor/q3-fy2026">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption> </figure>
https://whoreportstoday.com/t/cor/q3-fy2026/sankey.png
<a href="https://whoreportstoday.com/t/cor/q3-fy2026">COR Q3 FY2026 earnings chart (Who Reports Today)</a>
This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.
- Operating income was $1.12B, a 1.3% margin vs 1.1% a year earlier.
- The effective tax rate was 22.0% vs 23.0% a year earlier.
What distorts the picture in this report and what to watch beyond the headlines.
COR — a pharmaceutical sourcing and distribution company that supplies brand-name, specialty and generic drugs and related services to hospitals, pharmacies, clinics, physician practices and veterinarians, and offers drug makers logistics, data and consulting services.
It reports two segments: U.S. Healthcare Solutions and International Healthcare Solutions. · Source: annual report (Form 10-K, SEC)
More reports: CRL · Q3 2026 · CVS · Q3 2026 · DGX · Q3 2026 · DHR · Q3 2026 · DVA · Q3 2026 · DXCM · Q3 2026 · ELV · Q3 2026 · EW · Q2 2026 · GEHC · Q3 2026 · GILD · Q3 2026 · all reports